Shuji Arakawa

Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis

Tokyo, Kazumichi Yoshida, K. Kario, 2022, Hypertension Research.

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset

Y. Kondo, Y. Nagakane, Y. Yagita, 2019, Journal of the American Heart Association.

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

K. Kario, N. Kitamura, Y. Nakajima, 2020, Diabetes Therapy.

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan

M. Ezura, K. Toyoda, T. Masuno, 2023, Journal of atherosclerosis and thrombosis.